CINDY DOMINGUEZ: Open Payments
NPI 1164088514 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 88 payments from 21 companies in 2025. Trend: 2023 $451 · 2024 $1,295 · 2025 $1,489
Food & beverage: $1,447Education: $43
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 35 | $332 |
| Mannkind Corporation | 7 | $170 |
| Dexcom, Inc. | 5 | $111 |
| Novo Nordisk Inc | 5 | $99 |
| CeQur Corporation | 1 | $99 |
| Lilly USA, LLC | 5 | $90 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| BETA BIONICS, INC. | 3 | $72 |
| Ascendis Pharma Endocrinology Inc | 2 | $59 |
| Amgen Inc. | 4 | $56 |
Products named: Omnipod, AFREZZA, Dexcom G6 Transmitter, CeQur Simplicity, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, Yorvipath.
Industry payments across KS — which companies pay providers there.
